日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial"

更正:“在QuANTUM-First试验中,造血细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响”

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

FLT3-ITD measurable residual disease from the QuANTUM-First trial

Quantum-First试验中FLT3-ITD可测量残留病灶

Levis, Mark J; Erba, Harry P; Montesinos, Pau; Kim, Hee-Je; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Connolly Rohrbach, Jaime E; Chang, Ken C N; Liu, Li; Mostafa Kamel, Yasser; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Schlenk, Richard F; Perl, Alexander E

Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML

对于FLT3-ITD突变型急性髓系白血病患者,可测量的残留病灶和移植后吉瑞替尼维持治疗。

Levis, Mark J; Hamadani, Mehdi; Logan, Brent R; Jones, Richard J; Singh, Anurag K; Litzow, Mark R; Wingard, John R; Papadopoulos, Esperanza B; Perl, Alexander E; Soiffer, Robert J; Ustun, Celalettin; Oshima, Masumi Ueda; Uy, Geoffrey L; Waller, Edmund K; Vasu, Sumithira; Solh, Melhem; Mishra, Asmita; Muffly, Lori S; Kim, Hee-Je; Stelljes, Matthias; Najima, Yuho; Onozawa, Masahiro; Thomson, Kirsty; Nagler, Arnon; Wei, Andrew H; Marcucci, Guido; Chen, Caroline; Hasabou, Nahla; Rosales, Matt; Hill, Jason; Gill, Stanley C; Nuthethi, Rishita; King, Denise; Mendizabal, Adam; Devine, Steven M; Horowitz, Mary M; Chen, Yi-Bin

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

使用revumenib抑制Menin治疗NPM1突变复发或难治性急性髓系白血病:AUGMENT-101研究

Arellano, Martha L; Thirman, Michael J; DiPersio, John F; Heiblig, Maël; Stein, Eytan M; Schuh, Andre C; Žučenka, Andrius; de Botton, Stephane; Grove, Carolyn S; Mannis, Gabriel N; Papayannidis, Cristina; Perl, Alexander E; Issa, Ghayas C; Aldoss, Ibrahim; Bajel, Ashish; Dickens, David S; Kühn, Michael W M; Mantzaris, Ioannis; Raffoux, Emmanuel; Traer, Elie; Amitai, Irina; Döhner, Hartmut; Greco, Corinna; Kovacsovics, Tibor; McMahon, Christine M; Montesinos, Pau; Pigneux, Arnaud; Shami, Paul J; Stone, Richard M; Wolach, Ofir; Harpel, John G; Chudnovsky, Yakov; Yu, Li; Bagley, Rebecca G; Smith, Angela R; Blachly, James S

Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial

急性早幼粒细胞白血病和早期死亡率的学术界合作:ECOG-ACRIN EA9131试验

Jillella, Anand P; Lee, Sandra J; Altman, Jessica K; Luger, Selina M; Tallman, Martin S; Foran, James M; Bradshaw, Danielle; Law, Lisa Y; Bryan, Locke J; Abou Zahr, Abdallah; Begna, Kebede H; Perl, Alexander E; Vadakara, Joseph J L; Qamar, Rubina; Bergan, Raymond C; Fisch, Michael J; Carlos, Ruth C; Wagner, Lynne I; Kota, Vamsi K; Litzow, Mark R

Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial

在QuANTUM-First试验中,造血干细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žak, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Herve; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia

获得性 BCL2 变异与急性髓系白血病中维奈托克耐药性相关

Brown, Fiona C; Wang, Xin; Birkinshaw, Richard; Chua, Chong Chyn; Morley, Thomas; Kasapgil, Sila; Pomilio, Giovanna; Blombery, Piers; Huang, David C S; Czabotar, Peter; Priore, Salvatore F; Yang, Guang; Carroll, Martin; Wei, Andrew H; Perl, Alexander E

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

移植预处理、NPM1突变和可测量残留病灶对FLT3-ITD急性髓系白血病的影响

Levis, Mark J; Hamadani, Mehdi; Logan, Brent R; Jones, Richard J; Singh, Anurag K; Litzow, Mark R; Wingard, John R; Papadopoulos, Esperanza B; Perl, Alexander E; Soiffer, Robert J; Ustun, Celalettin; Oshima, Masumi Ueda; Uy, Geoffrey L; Waller, Edmund K; Vasu, Sumithira; Solh, Melhem; Mishra, Asmita; Muffly, Lori S; Kim, Hee-Je; Stelljes, Matthias; Najima, Yuho; Onozawa, Masahiro; Thomson, Kirsty; Chen, Caroline; Hasabou, Nahla; Rosales, Matt; Hill, Jason E; Gill, Stanley C; Nuthethi, Rishita; King, Denise; Mendizabal, Adam; Devine, Steven M; Horowitz, Mary M; Chen, Yi-Bin

Evolving racial/ethnic disparities in AML survival in the novel therapy era

新疗法时代急性髓系白血病生存率中不断演变的种族/民族差异

Wang, Xin; Gimotty, Phyllis A; Matthews, Andrew H; Mamtani, Ronac; Luger, Selina M; Hexner, Elizabeth O; Babushok, Daria V; McCurdy, Shannon R; Frey, Noelle V; Bruno, Ximena Jordan; Gill, Saar; Martin, Mary Ellen; Paralkar, Vikram R; Maillard, Ivan; Porter, David L; Loren, Alison W; Perl, Alexander E; Pratz, Keith W; Getz, Kelly D; Lai, Catherine

Cytokine-mediated CAR T therapy resistance in AML

急性髓系白血病中细胞因子介导的CAR-T疗法耐药性

Bhagwat, Anand S; Torres, Leonel; Shestova, Olga; Shestov, Maksim; Mellors, Patrick W; Fisher, Hansen R; Farooki, Saamia N; Frost, Benjamin F; Loken, Michael R; Gaymon, Avery L; Frazee, Diane; Rogal, Walter; Frey, Noelle; Hexner, Elizabeth O; Luger, Selina M; Loren, Alison W; Martin, Mary Ellen; McCurdy, Shannon R; Perl, Alexander E; Stadtmauer, Edward A; Brogdon, Jennifer L; Fraietta, Joseph A; Hwang, Wei-Ting; Siegel, Don L; Plesa, Gabriela; Aplenc, Richard; Porter, David L; June, Carl H; Gill, Saar I